SEC Form 4 · accession 0001209191-17-045945
GENOMIC HEALTH INC · GHDX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Phillip G. Febbo
Officer — Chief Medical Officer
Period of report
Jul 19, 2017
Accepted (ET)
Jul 21, 2017 · 4:20 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001131324
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2,F3,F4 | Jul 19, 2017 | S | 2,844 | $33.5654 | D | 18,130 | D | |
| Common StockF1,F5,F4 | Jul 19, 2017 | S | 330 | $33.57 | D | 17,800 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1These sales of common stock were effected pursuant to Rule 10b5-1 sales plan adopted by the reporting person on May 15, 2017.
- F2Represents weighted average sale price. Actual sale prices ranged from $33.31 to $33.80.
- F3Reporting person undertakes to provide upon request by the Securities and Exchange Commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares sold within the range indicated.
- F4Includes an aggregate of 17,800 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested.
- F5Represents actual sale price.